We are delighted to be partnering with the #IMMA conference.
If you're considering joining the conference register now. The early bird price is live and plenty of oral presentation slots are on offer.
For more information: bit.ly/4twsl2Z
Join us to her about some cutting-edge research at the joint virtual seminar, delivered by Dr Jonathan Noonan from the Baker Heart and Diabetes Institute
Join us at the AAS, AVBS and ANZMS virtual seminar today! unisa.zoom.us/j/87938462805?…
Abstracts are due soon! Don't miss out on the opportunity to present your work at the AAS ASM 2025. Submit using the link:
auth.oxfordabstracts.com/?re…
Abstract submission is open for our annual scientific meeting!
Submit via: app.oxfordabstracts.com/stag…
We are delighted to have @ChrisBursill representing Australia and the Asia Pacific on the IAS board!
The Council of Constituents Societies met on December 6 to vote on a new board of directors for the 2025-2027 term. The International Atherosclerosis Society is proud to announce its new board, effective January 1:
𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Dirk Blom, MBChB, MMed - South Africa
𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁-𝗘𝗹𝗲𝗰𝘁: Samia Mora, MD, MHS - United States
𝗦𝗲𝗰𝗿𝗲𝘁𝗮𝗿𝘆: Viviane Zorzanelli Rocha Giraldez, MD - Brazil
𝗧𝗿𝗲𝗮𝘀𝘂𝗿𝗲𝗿: Jessica Peña, MD, MPH - United States
𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗣𝗮𝘀𝘁 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Peter Libby, MD - United States
𝗘𝗹𝗲𝗰𝘁𝗲𝗱 𝗠𝗲𝗺𝗯𝗲𝗿𝘀 𝗮𝘁 𝗟𝗮𝗿𝗴𝗲:
Mutaz Al-Khnifsawi, MD - Iraq
Fahad Alnouri, MD, MSc - Saudi Arabia (@AlnouriDr)
Christina Bursill, PhD - Australia
Ioanna Gouni-Berthold, MD - Germany
Jianjun Li, MD, PhD - China
Maxima Mendez Castillo, MD - Dominican Republic
Manfredi Rizzo, MD, PhD - Italy
Banshi Saboo, MBBS, MD - India
Shizuya Yamashita, MD, PhD - Japan
Congrats to the newly elected board! Let's keep working together toward better prevention and care of atherosclerosis. #ISA2024 #CollaborateForImpact
SAHMRI PhD student, Demeke Geremew had a very engaged audience at the poster session! #ISA2024
Great representation by the AAS members at #ISA2024
Some excellent talks from @atheroaussie executives and members at the #ISA2024 . This marked last day group photo
@atherosociety
In her second talk for the morning, @ChrisBursill is delivering a sponsored lunchtime lecture on Inflammation in Atherosclerosis #ISA2024
Former AAS President and long time member, @ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024
Great to see more AAS member contribution at #ISA2024
Replying to @atheroaussie
@atheroaussie executive @kristenbubb presenting her research on plaque stability effects of Omega 3 at the ##ISA2024
@atherosociety
Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024
The AAS is equally proud of one of our Rising Stars, presenting at #ISA2024
Proud supervisor moment, @Misbah_Aziz1 presenting our epigenetics EndMT in atherosclerisis story at the #ISA2024 @atherosociety @atheroaussie
Exciting to see this international symposium on athero starting today!
#ISA2024
For the first time in-person since 2018, join IAS for #ISA2024 in Muskat, Oman.
Register today: bit.ly/4cL1W8h
See link below to submit your abstract for #EASCongress2025.
There are three travel bursaries available for AAS members to attend valued at €400 each!
⏳ Don’t miss the chance to present your research at #EASCongress2025!
This is your moment to share your latest findings & make an impact on the field of #atherosclerosis. Submit your abstract here ➡️ bit.ly/4fg36u4 #AtherosclerosisResearch #HeartHealthExperts
Closing out the FH Summit is the interactive workshop focusing on the development of risk-reduction pathway for children led by @MitchellSarkies with insights from Shubha Srinivasan, Natalie Taylor & Andrew Martin.























